Patents-Review.com
🔗 Permalink
Assignee profile:

IntelGenx Corp.

City:

St.-Laurent

Country:

Canada

Published Applications:

23

Last publication date:

2025-04-17

Patent Grants:

8

Last grant date:

2024-04-16

Top Inventors for applications by IntelGenx Corp.

These are the the leading inventors for applications assigned to IntelGenx Corp.:

Recent patent applications by IntelGenx Corp.

IntelGenx Corp. based in St.-Laurent, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-17
US20250120908A1
Human necessities

ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE

 #2 | 2023-08-10
US20230248660A1
Human necessities

METHOD OF PREPARING LOXAPINE FILM ORAL DOSAGE FORM

 #3 | 2022-12-29
US20220409584A1
Human necessities

STABLE TRYPTAMINE ORAL FILMS

 #4 | 2021-10-14 ✅ Patent 11,957,785 granted on 2024-04-16
US20210315802A1
Human necessities

Film dosage form with extended release mucoadhesive particles

 #5 | 2020-07-09
US20200215063A1
Human necessities

SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME

 #6 | 2020-05-07 ✅ Patent 11,602,504 granted on 2023-03-14
US20200138730A1
Human necessities

Lipophilic active oral film formulation and method of making the same

 #7 | 2020-04-02 ✅ Patent 10,828,254 granted on 2020-11-10
US20200101008A1
Human necessities

Oral film formulation for modulating absorption profile

 #8 | 2019-09-26
US20190290595A1
Human necessities

DEVICE AND METHOD OF TREATING CONDITIONS ASSOCIATED WITH NEUROINFLAMMATION

 #9 | 2019-08-15
US20190247505A1
Human necessities

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

 #10 | 2019-08-01
US20190231685A1
Human necessities

ANTIHISTAMINE ORAL FILM DOSAGE FORM AND METHOD OF ADMINISTRATING SAME

 #11 | 2019-05-09
US20190133925A1
Human necessities

METHOD OF TREATMENT AND DEVICE FOR THE IMPROVED BIOAVAILABILITY OF LEUKOTRIENE RECEPTOR ANTAGONISTS

 #12 | 2019-01-03 ✅ Patent 11,648,212 granted on 2023-05-16
US20190000770A1
Human necessities

Loxapine film oral dosage form

 #13 | 2018-12-20 ✅ Patent 11,033,493 granted on 2021-06-15
US20180360736A1
Human necessities

Film dosage form with extended release mucoadhesive particles

 #14 | 2018-09-06
US20180250240A1
Human necessities

METHOD OF TREATMENT AND DEVICE FOR THE IMPROVED BIOAVAILABILITY OF LEUKOTRIENE RECEPTOR ANTAGONISTS

 #15 | 2018-08-16 ✅ Patent 10,722,476 granted on 2020-07-28
US20180228738A1
Human necessities

Device and method of treating conditions associated with neuroinflammation

 #16 | 2018-04-26
US20180110724A1
Human necessities

FILM DOSAGE FORM WITH MULTIMODAL AND PARTICLE SIZE DISTRIBUTIONS

 #17 | 2018-03-22
US20180078549A1
Human necessities

SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME

 #18 | 2017-09-14
US20170258710A1
Human necessities

MONTELUKAST TRANSMUCOSAL FILM

 #19 | 2017-08-03
US20170216220A1
Human necessities

LOXAPINE FILM ORAL DOSAGE FORM

 #20 | 2016-11-10
US20160324773A1
Human necessities

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

 #21 | 2016-08-25
US20160243036A1
Human necessities

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

 #22 | 2015-02-05 ✅ Patent 9,301,948 granted on 2016-04-05
US20150038540A1
Human necessities

Instantly wettable oral film dosage form without surfactant or polyalcohol

 #23 | 2008-02-07 ✅ Patent 7,674,479 granted on 2010-03-09
US20080031948A1
Human necessities

Sustained-release bupropion and bupropion/mecamylamine tablets

Also check out Intelgenx Corp.'s (St-Laurent, Canada) applicant profile with 11 patent applications submitted.

AssigneeID:

87398 ⎘